Home »
Aurobindo Pharma News
Aurobindo Pharma
Aurobindo Pharma unit gets first product approval from USFDA
Wed, Sep 11, 2024
TRENDING NOW
NPS vs SIP: Which can help generate larger corpus on Rs 12,000 monthly investment for 25 years; get calculations
Arkade Developers IPO allotment status: Check application status online using PAN - Step-by-step guide
Post-Results Analysis: Which Stocks to Buy? Insights by Anil Singhvi
Mon, May 27, 2024
Aurobindo unit gets USFDA nod to market generic asthma medication
Thu, Nov 30, 2023